UpFront
-
Deal Boost for Biocon
The firm is looking at partnerships with global pharma majors as a ticket to hasten the launch of its biotech products
-
Harsh Agarwal: Indian Firms Can Match Up to MNCs
Emami' s Director tells Forbes India that losing the bid for Paras Pharma is not a setback
-
Letter From the Editor: Clear and Present Opportunity
It isn't just about the big picture view. We've stuck our neck out to give you specific recommendations on how to play each asset class
-
Ravi Kiran: We Are Measured By Our Billing
Starcom MediaVest Group's outgoing CEO, South Asia tells Forbes India that in a margins-driven media industry, the focus is on getting the best rate, not on creativity
X